Sandy works with research sites, sponsors, and patient advocacy groups in support of WCG’s mission to accelerate the development of new medical therapies by improving the conduct and quality of clinical trials.  She provides consultation to research sites by strategically aligning clinical solutions to improve and create efficient processes in the areas of ethical review, biosafety, trial initiation, research financial services, staffing augmentation, and support for investigator-initiated trials with DSMBs, clinical endpoints, and statistical consulting.  With the many changes occurring in clinical research in 2025, she has spearheaded initiatives in research resilience with clinical trial stakeholders.  Prior to joining WCG in 2020, Sandy led a large oncology site management organization.